Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by SquishyIncon Apr 09, 2017 6:49pm
200 Views
Post# 26098352

RE:In comparison Canopy is way Undervalued !!!

RE:In comparison Canopy is way Undervalued !!!Remember this?

Duediligence33 wrote:

Market Capital Comparioson of 2 largest LP's
by mkt cap with Capacity to grow NOW

 

Aphria has a market cap of 776 million
Phase 1 in operation now has about 55,000 sq ft capacity

Phase 2 completed as of now adds 45,000 to 100,000 sq ft

                                       NOT YET APPROVED by HC - non operational

 

Aphria phase 3 another 200,000 sq ft still under mud and bulldozer
maybe Nov 2017
Then wait how long for HC approval


Aphria phase 4 another 600,000 sq ft will start in 2018 to 2019 completion then approval by 2020


Canopy has a market cap of about 2 x at 1,600 million
Bedrocan and Mettrum and Tweed Farms and Tweed Hershey

Weed already has over 500,000 sq ft in operation

Weed has 10 x capacity what Aphria has !!! right now

Tweed Hershey fully owned just tripled more space

And can go to 500,000 with same licence

 

Sure Aphria has positive EBITDA because it is still SMALL scale and they have 15,000 patients but Canopy has 50,000 patients

 

Canopy has already demonstrated industrial scale with $ 1,000,000 sales in ONE day on Feb 1, 2017

 

Either Aphria is overvalued or Canopy is Undervalued

 

If Aphria is $ 6.25 then Canopy should be minimum a double or more
                at $ 12.50 to $ 14.00

 

Even without the Germany connection and Goldman and Vert etc etc

 

One investor paid over $ 24,000,000 for 2 million shares at  $ 9.70 !!!!

 

I am not a chart man but my opinion we have seen the bottom form in the last 3 days

 

Higher Highs  $ 10.00 and $ 10.16 then $ 10. 28

Higher Lows   $   9.51 and close $ 9.72 then $   9.80  and close $ 9.88




Bullboard Posts